Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Ideas
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Tools
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
More
Plans
News
Trending
Portfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Ideas
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Tools
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
Log Out
LTRN
Stock Latest News
Company Announcements
Lantern Pharma Q2 Results and LP-300 Clinical Trial Update
1M ago
8K
LTRN
Premium
The Fly
Lantern Pharma reports Q2 EPS (46c), one estimate (55c)
1M ago
LTRN
Premium
The Fly
Lantern Pharma highlights ‘promising’ prelinical results of LP-184
1M ago
LTRN
Premium
The Fly
Lantern updates ongoing Phase 2 HARMONIC trial for ‘Never Smokers’
2M ago
LTRN
Premium
The Fly
Lantern progresses toward diagnostic for LP-184 for oncology clinical trials use
2M ago
LTRN
Premium
The Fly
Lantern receives certificate of patent from Japan Patent Office for LP-284
3M ago
LTRN
Premium
The Fly
Lantern Pharma files $150M mixed securities shelf
4M ago
LTRN
Premium
The Fly
Lantern Pharma reports Q1 EPS (51c) , one estimate (43c)
4M ago
LTRN
Premium
The Fly
Lantern Pharma enters AI-driven collaboration with Oregon Therapeutics
5M ago
LTRN
Premium
The Fly
Lantern Pharma receives regulatory approval to expand Harmonic trial
5M ago
LTRN
Premium
Company Announcements
Lantern Pharma’s Triple Threat: Inflation, Global Tensions, and Pandemic Impacts Jeopardize Financial Health
6M ago
LTRN
Premium
Company Announcements
Lantern Pharma Announces Fiscal Year and Q4 Results Webinar
6M ago
8K
LTRN
Premium
The Fly
Lantern Pharma reports Q4 EPS (39c), two estimates (40c)
6M ago
LTRN
Premium
The Fly
Lantern Pharma doses first two patients in LP-284 trial
6M ago
LTRN
Premium
Pre-Earnings
LTRN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
7M ago
LTRN
Premium
The Fly
Lantern Pharma generates new class of ADCs with cryptophycin drug-payload
7M ago
LTRN
Premium
The Fly
Lantern Pharma receives Orphan Drug Designation from FDA for LP-284
10M ago
LTRN
Premium
The Fly
Lantern Pharma treatment of diffuse large B-cell lymphoma granted orphan status
10M ago
LTRN
Premium
The Fly
Lantern Pharma:Data on for LP-184 for GBM published in Clinical Cancer Research
12M ago
LTRN
Premium
The Fly
Lantern Pharma announces first patient dosed in Phase 1 study for LP-184
12M ago
LTRN
Premium
The Fly
Lantern Pharma announces FDA clearance of LP-284 IND application
1y ago
LTRN
Premium
The Fly
Lantern Pharma receives notice of allowance from USPTO for ATRT treatment
1y ago
LTRN
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
